CNXU — Conexeu Sciences Cashflow Statement
0.000.00%
Annual cashflow statement for Conexeu Sciences, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.036 | -0.472 | -3.92 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 0 | 0.007 | 2.18 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.031 | 0.239 | 0.054 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.004 | -0.225 | -1.67 |
| Capital Expenditures | — | 0 | -0.019 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 0 | -0.071 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | 0 | -0.09 |
| Financing Cash Flow Items | 0.004 | 0.535 | 6.38 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.004 | 0.535 | 6.28 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.315 | 4.52 |